A detailed history of Broadwater Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Broadwater Capital Management LLC holds 8,900 shares of BMY stock, worth $410,023. This represents 0.29% of its overall portfolio holdings.

Number of Shares
8,900
Previous 8,900 -0.0%
Holding current value
$410,023
Previous $122 Million 230.33%
% of portfolio
0.29%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2025

SELL
$39.66 - $51.75 $62,662 - $81,765
-1,580 Reduced 15.08%
8,900 $460 Million
Q2 2024

Oct 30, 2025

SELL
$40.25 - $52.99 $190,785 - $251,172
-4,740 Reduced 31.14%
10,480 $435 Million
Q4 2023

Oct 30, 2025

BUY
$48.48 - $57.85 $737,865 - $880,477
15,220 New
15,220 $781 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $98B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Broadwater Capital Management LLC Portfolio

Follow Broadwater Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadwater Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadwater Capital Management LLC with notifications on news.